Cognex (CGNX) director converts 8,324 RSUs into stock, now holds 30,518 shares

Rhea-AI Filing Summary

COGNEX CORP director Dianne M. Parrotte reported equity award activity involving restricted stock units and common shares. On February 18, 2026, she exercised or converted 8,324 restricted stock units into 8,324 shares of Cognex common stock at a stated price of $0.00 per share, increasing her direct common stock holdings to 30,518 shares.

The filing also lists updated direct holdings of several non-qualified stock options with rights to buy 7,500, 18,400 and 18,100 shares, and 2,913 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Cognex common stock and vests 100% on the first anniversary of the grant date, stated as February 18, 2025.

Insider Trade Summary

8,324 shares exercised/converted

Mixed 6 txns

Insider PARROTTE DIANNE M

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	8,324	$0.00	--
Exercise	Common Stock	8,324	$0.00	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct); Common Stock — 30,518 shares (Direct); Non-Qualified Stock Option (right to buy) — 7,500 shares (Direct)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PARROTTE DIANNE M

(Last) (First) (Middle)

ONE VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		M		8,324	A	$0.0	30,518	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/18/2026		M			8,324	02/18/2026(2)	02/18/2026	Common Stock	8,324	$0.0	0	D
Non-Qualified Stock Option (right to buy)	$45.06							05/02/2019	05/02/2028	Common Stock	7,500		7,500	D
Non-Qualified Stock Option (right to buy)	$50.94							02/18/2021	02/18/2030	Common Stock	18,400		18,400	D
Non-Qualified Stock Option (right to buy)	$51.49							02/19/2020	02/19/2029	Common Stock	18,100		18,100	D
Restricted Stock Unit	$0.0							02/21/2024	02/21/2026	Common Stock	2,913		2,913	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).

	Dianne M. Parrotte	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cognex (CGNX) director Dianne Parrotte report?

Director Dianne M. Parrotte reported exercising or converting 8,324 restricted stock units into 8,324 shares of Cognex common stock at a stated price of $0.00 per share, increasing her direct common stock holdings to 30,518 shares on February 18, 2026.

How many Cognex (CGNX) shares does Dianne Parrotte own after this Form 4?

After the reported transactions, Dianne M. Parrotte directly holds 30,518 shares of Cognex common stock. This figure reflects the conversion of 8,324 restricted stock units into common shares on February 18, 2026, as disclosed in the Form 4 filing.

What happened to Dianne Parrotte’s restricted stock units in Cognex (CGNX)?

On February 18, 2026, 8,324 restricted stock units were exercised or converted into 8,324 Cognex common shares. Each unit represented a contingent right to one share and was scheduled to vest 100% on the first anniversary of the grant date, February 18, 2025.

What Cognex (CGNX) stock options does Dianne Parrotte hold after the filing?

The Form 4 shows updated holdings of non-qualified stock options with rights to buy 7,500, 18,400 and 18,100 Cognex shares. These figures represent her direct option positions following the February 18, 2026 reporting date, without specifying new exercises for those options.

How do Cognex (CGNX) restricted stock units reported here vest?

Each restricted stock unit represents a contingent right to receive one Cognex common share. The filing states these units vest 100% on the first anniversary of the grant date, identified as February 18, 2025, before being eligible for conversion into common stock.

Does the Cognex (CGNX) Form 4 show any share sales by Dianne Parrotte?

The disclosed transactions show an exercise or conversion of 8,324 restricted stock units into common shares with no reported sales. The filing describes these as derivative exercises or conversions, increasing her direct common stock holdings to 30,518 shares after the transactions.